Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (381-390 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|November 15, 1992
Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic studyJ J Popma, R M Califf, S G Ellis, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
Journal of the American College of Cardiology|June 1, 1988
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarctionR S Stack, R M Califf, T Hinohara, et al.
Archives of Internal Medicine|January 13, 1997
Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of TreatmentJ D FitzGerald, N S Wenger, R M Califf, et al.
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Journal of the American College of Cardiology|October 1, 1994
Predicting the risk of abrupt vessel closure after angioplasty in an individual patientA N Tenaglia, D F Fortin, R M Califf, et al.
Archives of Internal Medicine|August 30, 2001
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failureW Jiang, J Alexander, E Christopher, et al.
Circulation|June 14, 2000
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI InvestigatorsM M Brooks, R H Jones, R G Bach, et al.
Pageof 57

Showing results (381-390 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|November 15, 1992
Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic studyJ J Popma, R M Califf, S G Ellis, et al.
Journal of the American College of Cardiology|February 1, 1991
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
Journal of the American College of Cardiology|June 1, 1988
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarctionR S Stack, R M Califf, T Hinohara, et al.
Archives of Internal Medicine|January 13, 1997
Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of TreatmentJ D FitzGerald, N S Wenger, R M Califf, et al.
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Journal of the American College of Cardiology|October 1, 1994
Predicting the risk of abrupt vessel closure after angioplasty in an individual patientA N Tenaglia, D F Fortin, R M Califf, et al.
Archives of Internal Medicine|August 30, 2001
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failureW Jiang, J Alexander, E Christopher, et al.
Circulation|June 14, 2000
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI InvestigatorsM M Brooks, R H Jones, R G Bach, et al.
Pageof 57